Francesca Panza

Siena, 53100, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Antigen-agnostic identification of poxvirus broadly neutralizing antibodies targeting OPG153.

Antigen-agnostic identification of poxvirus broadly neutralizing antibodies targeting OPG153.

Journal: Science translational medicine
Published: December 10, 2025

Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses.

Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses.

Journal: EBioMedicine
Published: May 14, 2024

PRESTIGIO RING "a 59-year-old man with multidrug resistant HIV-1 infection failing a regimen including dolutegravir, rilpivirine, atazanavir/cobicistat: successful treatment tailoring based on genotypic and phenotypic resistance tests".

PRESTIGIO RING "a 59-year-old man with multidrug resistant HIV-1 infection failing a regimen including dolutegravir, rilpivirine, atazanavir/cobicistat: successful treatment tailoring based on genotypic and phenotypic resistance tests".

Journal: The new microbiologica
Published: May 03, 2024

Antigenic sin and multiple breakthrough infections drive converging evolution of COVID-19 neutralizing responses.

Antigenic sin and multiple breakthrough infections drive converging evolution of COVID-19 neutralizing responses.

Journal: Cell reports
Published: April 29, 2024

Hepatitis C epidemiology and treatment outcomes in Italy: Impact of the DAA era and the COVID-19 pandemic.

Hepatitis C epidemiology and treatment outcomes in Italy: Impact of the DAA era and the COVID-19 pandemic.

Journal: Journal of viral hepatitis
Published: February 29, 2024

Primary Cutaneous Cryptococcosis in an Immunocompetent Patient: Diagnostic Workflow and Choice of Treatment.

Primary Cutaneous Cryptococcosis in an Immunocompetent Patient: Diagnostic Workflow and Choice of Treatment.

Journal: Diagnostics (Basel, Switzerland)
Published: September 21, 2023

Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound?

Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound?

Journal: Microorganisms
Published: September 10, 2023

Efficacy and Durability of Dolutegravir- or Darunavir-Based Regimens in ART-Naïve AIDS- or Late-Presenting HIV-Infected Patients.

Efficacy and Durability of Dolutegravir- or Darunavir-Based Regimens in ART-Naïve AIDS- or Late-Presenting HIV-Infected Patients.

Journal: Viruses
Published: April 07, 2023
Showing 1-8 of 8

Last Updated: 09/26/2026